Literature DB >> 9009096

Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation.

J Boer1, H Mahmoud, S Raimondi, G Grosveld, R Krance.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009096     DOI: 10.1038/sj.leu.2400554

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Localized relapse in bone marrow in a posttransplantation patient with t(6;9) acute myeloid leukemia.

Authors:  Tetsuo Maeda; Satoru Kosugi; Hidetoshi Ujiie; Kazuoki Osumi; Takashi Fukui; Hitoshi Yoshida; Hirokazu Kashiwagi; Jun Ishikawa; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.490

2.  High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.

Authors:  Nirit Mor-Vaknin; Miguel Rivas; Maureen Legendre; Smriti Mohan; Ye Yuanfan; Theresa Mau; Anne Johnson; Bin Huang; Lili Zhao; Yukiko Kimura; Steven J Spalding; Paula W Morris; Beth S Gottlieb; Karen Onel; Judyann C Olson; Barbara S Edelheit; Michael Shishov; Lawrence K Jung; Elaine A Cassidy; Sampath Prahalad; Murray H Passo; Timothy Beukelman; Jay Mehta; Edward H Giannini; Barbara S Adams; Daniel J Lovell; David M Markovitz
Journal:  Arthritis Rheumatol       Date:  2018-02-22       Impact factor: 10.995

3.  DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression.

Authors:  Mai-Qing Yang; Lin-Lin Bai; Zhao Wang; Lei Lei; Yi-Wen Zheng; Zhi-Han Li; Wen-Jing Huang; Chen-Chen Liu; Hong-Tao Xu
Journal:  Oncol Lett       Date:  2021-04-01       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.